EU-INTERREG „RescKUE“
Laufzeit: 01.01.2021 - 31.12.2023
imported
Kurzfassung
prospective, randomised, double blind, placebo-controlled multicenter study to evaluate the effects of spironolacton in patients with rheumatoid arthritis
